Cigna Group (The) NYSE:CI Price, Chart, News & Insight

Cigna and OpenAI Partner to Bring AI-Powered Support to Patients With Complex Conditions

The Cigna Group and OpenAI announced a collaboration aimed at improving care for patients with complex health conditions, with the first capabilities focused on oncology.

Cigna plans to integrate OpenAI’s frontier reasoning models into clinical workflows and customer experiences to help identify emerging patient needs earlier, personalize support and improve care coordination between doctor visits. The initial oncology use cases are intended to help patients navigate treatment side effects, new symptoms, questions and next steps throughout their cancer journey.

One of the first applications will support oncology nurses and case managers across Accredo Specialty Pharmacy and Cigna Healthcare. The system will combine clinical, pharmacy, behavioral and benefits information to provide a more complete view of each patient and help care teams determine appropriate support.

Cigna said the partnership is also designed to create a continuous learning loop using patient responses, reported side effects, navigation needs and communication preferences to improve future guidance and clinical workflows. Over time, the companies expect to expand AI-enabled health intelligence capabilities beyond oncology to a broader range of conditions.

The companies emphasized that clinicians will remain responsible for care decisions. Cigna also said patient and member data will not be retained by OpenAI or used to train OpenAI models.

💬

The Investor 09-23-26

The Cigna Group reported strong first-quarter 2026 results and raised its full-year outlook, supported by broad-based growth and improved efficiency.

Total revenue increased 5% year-over-year to $68.5 billion, while net income rose to $1.7 billion, or $6.26 per share, up from $1.3 billion a year earlier. Adjusted income from operations reached $2.1 billion, with adjusted EPS of $7.79, reflecting a 12% increase.

Performance was driven by continued strength in both Cigna Healthcare and Evernorth Health Services, alongside disciplined cost management. The company also improved its efficiency, with the adjusted SG&A expense ratio declining to 4.8% from 5.8% a year earlier.

Looking ahead, Cigna raised its 2026 adjusted EPS outlook to at least $30.35, signaling confidence in sustained earnings growth.

Source: PR Newswire

💬

Global Finance News 04-30-26

Cigna Group (NYSE: CI) declared a cash dividend of $1.56 per share of its common stock, payable on June 18, 2026, to shareholders of record as of the close of business on June 4, 2026.

💬

The Investor 04-24-26

The Cigna Group (NYSE:CI) will release its first quarter 2026 financial results on Thursday, April 30, 2026,

💬

Global Finance News 04-03-26

The Cigna Group announced that it will release its fourth quarter 2025 financial results on Thursday, February 5, 2026. The earnings release will be published no later than 6:30 a.m. Eastern Time, followed by a management conference call at 8:30 a.m. ET to review the results.

The company stated that the earnings call will be accessible via live dial-in and webcast, with a replay available later the same day and remaining accessible through February 19, 2026. Supporting materials, including the earnings release and financial supplement, will be posted in the Investor Relations section of The Cigna Group’s website on the morning of the announcement.

Source: The Cigna Group, PR Newswire, January 13, 2026

💬

The Investor 01-13-26

Cigna Reports Double-Digit Revenue Growth and Strong Q3 Earnings, Reaffirms 2025 Outlook

The Cigna Group (NYSE: CI) posted third-quarter 2025 revenue of $69.7 billion, up 10% year over year. Shareholders’ net income rose to $1.9 billion, or $6.98 per share, compared to $0.7 billion in the prior year, while adjusted income from operations remained strong at $2.1 billion, or $7.83 per share. The company reaffirmed its 2025 full-year adjusted EPS outlook of at least $29.60 and unveiled a new rebate-free pharmacy benefit model aimed at lowering costs, improving transparency, and supporting local pharmacies.

💬

Global Finance News 10-30-25

The Cigna Group (NYSE:CI) will release its third quarter 2025 financial results on Thursday, October 30, 2025, and will host a conference call the same day.

💬

WS Investor 10-02-25

Malta House of Care has opened a new mobile health clinic site in East Hartford, Connecticut, supported by a two-year grant from The Cigna Group Foundation’s Health Equity Impact Fund. Operating twice a month from St. Mary’s Church Community Center, the clinic will provide more than 1,000 patient visits annually, offering free primary care to uninsured adults for chronic conditions, urgent needs, and preventive services such as screenings and vaccinations.

About 15% of adults in East Hartford are uninsured, and the new site expands Malta’s reach in Greater Hartford, where it has served as a trusted provider of free care for two decades. “We’re proud to join forces with The Cigna Group Foundation to expand access to care for those who need it most,” said Malta House CEO Dianne Auger.

Ellie Polack, president of The Cigna Group Foundation, emphasized the initiative’s role in reducing barriers to care: “People shouldn’t have to choose between health care and other basic necessities.” The project builds on Malta’s mission of health equity and The Cigna Group Foundation’s commitment to improving outcomes in underserved communities.

💬

The Investor 09-23-25

Evernorth Health Services (The Cigna Group) Invests $3.5B in Shields Health Solutions

BLOOMFIELD, Conn., Sept. 2, 2025 — Evernorth Health Services, a subsidiary of The Cigna Group (NYSE: CI), announced a $3.5 billion preferred stock investment in Shields Health Solutions, a leading specialty pharmacy management company.

The investment coincides with Shields’ transition to a private standalone company, following its acquisition by Sycamore Partners from Walgreens Boots Alliance, which closed on August 28, 2025.

Evernorth said the investment supports the growing market for specialty medicine and aligns with its strategy to enhance care for people with complex and chronic conditions. The deal is not expected to impact Cigna’s 2025 adjusted EPS guidance of at least $29.60.

Shields partners with over 80 health systems and 1,000+ hospitals and clinics nationwide, helping them build and manage specialty pharmacies. Evernorth’s expanded relationship with Shields aims to strengthen care continuity across specialty healthcare settings and provide additional investment opportunities over time.

💬

The Investor 09-02-25

Cigna Q2 2025: Revenue Up 11%, EPS Outlook Reaffirmed

The Cigna Group (NYSE: CI) posted Q2 2025 total revenues of $67.2 billion, up 11% year-over-year. Shareholders' net income was $1.5 billion ($5.71 per share), flat compared to $1.5 billion ($5.45 per share) in Q2 2024. Adjusted income from operations rose to $1.9 billion ($7.20 per share), from $1.9 billion ($6.72 per share) last year.
CEO David Cordani attributed the strong performance to disciplined execution and a resilient business mix. The company reaffirmed its full-year 2025 outlook for adjusted income from operations of at least $29.60 per share.

💬

Global Finance News 07-31-25

NYSE:CIFollow

NYSE:CI